Back to search

Article

Lactoferrin Reverses Methotrexate Driven Epithelial Barrier Defect by Inhibiting TGF-β Mediated Epithelial to Mesenchymal Transition

2019-12-26

Abstract excerpt

<h4>ABSTRACT</h4> <h4>BACKGROUND AND AIMS</h4> Methotrexate is an important tool in the arsenal of oncologists, gastroenterologists, and rheumatologists. At low doses it induces intestinal barrier dysfunction that may induce side effects such as gastrointestinal discomfort and liver injury. Previous studies suggest that lactoferrin can improve barrier function in a variety of contexts. This study set out to dete...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e63da53f-9524-52f7-aae3-3db481d18f3d
DOI
10.1101/2019.12.23.878207
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Lactoferrin Reverses Methotrexate Driven Epithelial Barrier Defect by Inhibiting TGF-β Mediated Epithelial to Mesenchymal TransitionDOI 10.1101/2019.12.23.878207
Select a neighboring publication to make it the new centre.